Fig. 8.
Fig. 8. Control (C) and leukemic (L) samples from patient P32, used to create the cell lines 183-Ccl and 183-E95, respectively, and leukemic sample from patient 28 were HindIII digested, fractionated on 1% agarose, and hybridized with the following probes: (A) control probe bcl-1; (B) p9E4.3, with densitometry results compared with control signals of 0.45 and 0.45, respectively, showing hemizygous loss and hemizygous loss, respectively; and (C) probe p6E.32, with densitometry results compared with control signals of 0.02 and 0.79 showing homozygous loss and biallelic retention, respectively.

Control (C) and leukemic (L) samples from patient P32, used to create the cell lines 183-Ccl and 183-E95, respectively, and leukemic sample from patient 28 were HindIII digested, fractionated on 1% agarose, and hybridized with the following probes: (A) control probe bcl-1; (B) p9E4.3, with densitometry results compared with control signals of 0.45 and 0.45, respectively, showing hemizygous loss and hemizygous loss, respectively; and (C) probe p6E.32, with densitometry results compared with control signals of 0.02 and 0.79 showing homozygous loss and biallelic retention, respectively.

Close Modal

or Create an Account

Close Modal
Close Modal